NP48925b Hereditary Angioedema Branded Medicines (Berinert)
A Contract Award Notice
by THE COMMON SERVICES AGENCY (MORE COMMONLY KNOWN AS NHS NATIONAL SERVICES SCOTLAND) (NSS)
- Source
- Find a Tender
- Type
- Framework (Goods)
- Duration
- not specified
- Value
- £5M
- Sector
- HEALTH
- Published
- 02 May 2025
- Delivery
- not specified
- Deadline
- n/a
Concepts
Location
All entities constituted pursuant to the National Health Service (Scotland) Act 1978, and any Integrated Joint Boards established pursuant to the new Public Bodies (Joint Working) Scotland Act 2014
1 buyer
- NHS National Services Scotland NSS Edinburgh
1 supplier
- CSL Behring Haywards Heath
Description
Supply of C1-esterase inhibitor human powder and solvent for solution for injection vials (various strengths) (Berinert®) to NHS Scotland.
Total Quantity or Scope
The Framework Agreement is for the supply of hereditary angioedema (HAE) branded medicines to NHS Scotland. The Framework Agreement has been awarded as a single supplier framework agreement to one (1) Framework Participant.
Award Detail
| 1 | CSL Behring (Haywards Heath)
|
Award Criteria
| price | _ |
CPV Codes
- 33600000 - Pharmaceutical products
Legal Justification
Competition for the medicine awarded to the Framework Agreement is absent for technical reasons, in accordance with Regulation 33(1)(b)(ii) of the Public Contracts (Scotland) Regulations 2015.
Other Information
** PREVIEW NOTICE, please check Find a Tender for full details. ** The estimated value(s) referred to in Section II.1.7 and Section V.2.4 covers the twenty-four (24) month Framework Agreement duration and the twenty-four (24) month extension period of the Framework Agreement. Details of individual lines awarded can be requested from the named person at the head of this notice. (SC Ref:797706)
Reference
- ocds-h6vhtk-04fd8f
- FTS 018678-2025